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The transduction of a signal is a change in form of the 
signal as it is passed from one carrier to another. The root 
"duce" means"to lead" in Latin; thus, a signal is led through 
a cell by steps of transduction (the same root is in the 
words seduce and duct as well as II Duce). The earliest 
transduction steps that were elucidated involved massive 
release of small molecule "second messengers", originally 
cAMP, that flooded a cell with information. With the under- 
standing that such proteins as tyrosine kinases and Ras 
relatives are signal transducers, came the realization that 
many signaling pathways are more precise, sending con- 
trolled and probably weakly amplified signals to specific 
targets. These intracellular signals are often maintained 
in macromolecular form rather than being passed to small 
molecules. 
The proteins that carry these signals are not acting in 
the classic fashion of enzymes that are designed to modify 
large numbers of substrate molecules. These signal trans- 
ducers, even if they catalyze an event such as phosphory- 
lation, generally affect small numbers of target molecules 
and have often separated their catalytic function from their 
binding regions, which can bring substrates to the catalytic 
centers, link the signal transducers to upstream proteins, 
and localize protein complexes to particular cellular subre- 
gions. The binding domains are often modular ones con- 
structed with a common core recognition ability coupled 
to a fine specificity control. They modulate the interaction 
of proteins with other proteins and therefore determine the 
paths of signal transduction systems. They are generally 
controlled, also, so that the aggregates they form are tran- 
sient, pathways forming only when the signal is being 
transmitted and then disaggregating when the signal has 
passed. The signal transduction protein must be highly 
integrated, with all of the elements working together to 
send just the appropriate quanta of signal for the spe- 
cific need. 
The preceding paragraphs are generalizations based on 
scanty and fragmentary evidence. With many transduction 
pathways known only in outline and more sure to be found, 
there is a deeply exciting richness yet to be elucidated. But 
many investigators are now working within the framework 
presented above, trying to find the relevant units and un- 
derstand their integration. 
Protein-protein interaction has long been studied, but 
the realization of the importance of defined binding rood- 
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ules came with the recognition that the Rous sarcoma 
virus oncogene, src, has not only a tyrosine kinase cata- 
lytic domain but also two other domains that re held in 
common with proteins that either do or do not have kinase 
domains. First came the SH2 and then the SH3 domains 
(for Src homology modules) (Koch et al., 1991), which were 
later shown to be specific binding domains. Later still, 
the Pleckstrin homology (PH) domains were recognized 
(Mayer et al., 1993; Haslam et al., 1993). Many investiga- 
tors have their computers trained on recognizing other 
such domains, but no other large, modular families have 
been reported, suggesting that here may be few left 
to find. 
SH2, SH3, and PH domains have a few common proper- 
ties. First, they are true protein domains: they form com- 
pact units that maintain their structures in isolation, and 
each has its N- and C-termini in close apposition so that 
they can be plugged into the surface of proteins. They 
are not restricted to particular types of signal transduction 
proteins; they occur in protein kinases, lipid kinases, pro- 
tein phosphatases, phospholipases, Ras-controlling pro- 
teins, and even transcription factors, although they are 
rarely found in receptors. They are also found in adapter 
proteins such as Crk, which have no enzymatic function 
and appear to act solely to aggregate other proteins. SH3 
and PH domains are also seen in cytoskeleton proteins, 
where they may mediate the action of signal transduction 
pathways on cellular architecture and cell movement. 
There is no pattern to the number of these domains that 
occur in proteins, nor in their location within proteins (Fig- 
ure 1). PH and SH3 domains are found in all eukaryotic 
organisms, including yeast, while SH2 domains are not 
found in yeast. None of these domains are seen in prokary- 
otes (Koch et al., 1991; Mayer and Baltimore, 1993; Paw- 
son and Schlessinger, 1993; Musacchio et al., 1994b). 
This review will present our current understanding of 
how SH2, SH3, and PH domains are constructed, how 
they function, and how their activities are integrated into 
the general scheme of signal transduction. 
SH2 Domains 
In cells that respond to growth and differentiation factors 
through receptor tyrosine kinases (RTKs), among the most 
heavily phosphorylated proteins are the kinases them- 
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Figure 1. Examples of Proteins with SH2, SH3, and PH Domains 
Y-kinase, tyrosine kinase domain; PP, Pro-rich region that binds to
SH3 domains; DBD, DNA-binding domain; ABD, actin-binding domain; 
GAP, GTPase-activating domain. 
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selves. Autophosphorylation of the kinase is critical for 
transmitting signals to downstream molecules. In the early 
1990s, it became clear that most of the molecules that 
stably bind to phosphorylated RTKs contain SH2 domains. 
Subsequent work showed that SH2 domains by them- 
selves stably associate with Tyr-phosphorylated, but not 
unphosphorylated, RTKs (Mayer and Baltimore, 1993). 
The question then became, how specific are SH2-phos- 
phoprotein interactions? In other words, can an isolated 
SH2 domain, immersed in a sea of phosphoproteins, 
choose a specific binding partner? And if specific, how is 
the specificity encoded within the phosphoprotein and 
SH2 domain structures? The answers soon followed. 
Different SH2s bind to distinct phosphotyrosine (pTyr)- 
containing regions of the RTK. Mapping of the binding 
sites revealed that SH2 specificity is largely determined by 
the three residues immediately carboxyl to the pTyr, pTyr- 
X-X-X, where X-X-X varies for different SH2s. For example, 
a consensus binding site for the two SH2 domains of phos- 
phatidylinositol 3'-kinase (PI3K) is p-Tyr-(Val/Met)-X-Met. 
Site-directed mutations in the platelet-derived growth fac- 
tor receptor (PDGFR) at sites containing the consensus 
sequence--y74°MDM and YT~lVPM--severely disrupt bind- 
ing of PI3K to PDGFR. These mutations, however, do not 
affect the affinity of other SH2-containing molecules for 
the receptor, such as RasGAP (Cantley et al., 1991; Kaz- 
lauskas et al., 1992; Pawson and Schlessinger, 1993). 
Songyang et al. devised a systematic approach for de- 
termining the optimal peptide ligand for specific SH2 do- 
mains (Songyang et al., 1993, 1994). They synthesized 
an 8 amino acid phosphotyrosyl peptide library, random- 
ized at positions Y+I to Y+3 (the nomenclature refers to 
the residues carboxyl to the pTyr as +1, +2, etc.). Of the 
22 SH2 domains tested, each selected a unique peptide 
sequence, except for those from Src family proteins, all of 
which selected the sequence pYEEI (which might suggest 
that the Src family has redundant SH2 functions). Most 
SH2 domains fall into one of two broad categories: group 
I SH2s prefer pTyr-hydrophilic-hydrophilic-hydrophobic; 
group II SH2s select pTyr-hydrophobic-X-hydrophobic. In 
proteins that contain two SH2 domains, the SH2s may 
have either similar or different specificities (Songyang et 
al., 1993; Panayotou et al., 1993). On the basis of the 
unique motif recognized by an individual SH2 domain, pro- 
tein sequence data bases were searched for potential i- 
gands. In some cases, the proteins predicted to interact 
were found later to do so. 
Shoelson and colleagues have quantified the relative 
binding affinity of various - 12-mer phosphotyrosyl pep- 
tides for the N-terminal SH2 domains of the Syp phospha- 
tase and PI3K (Piccione et al., 1993; Case et al., 1994). 
Using a competition binding assay they demonstrated that 
the peptides display a continuum of affinities for SH2 do- 
mains ranging over three orders of magnitude (pTyr alone 
binds - 104-fold less tightly than the highest affinity pep- 
tides). When the lengths of the peptides were shortened 
from 12 amino acids to 6, there was little loss in affinity 
for the PI3K SH2 domain, as long as the N- and C-termini 
were blocked (Ac-X-pY-X-X-X-X-CONH2). However, the 
Syp SH2 domain behaved differently. Similar truncations 
in Syp-specific peptides severely diminished binding to 
the SH2 domain. We explore the physical basis for these 
different behaviors later. Measurements of the dissocia- 
tion constant (Kd) for SH2 domains and high affinity peptide 
ligands have ranged from <nM to the I~M range (Mayer 
and Baltimore, 1993); it appears that values of 20-100 nM 
are probably correct. 
What is the in vivo significance of different SH2 specifici- 
ties? Work by Pawson and coworkers begins to answer 
this question (Marengere et al., 1994). By changing a sin- 
gle residue in the Src SH2 domain, they switched its selec- 
tivity toward that of a SEM-5 SH2 domain. When the al- 
tered SH2 domain was spliced into the sem-5 gene, it 
provided SEM-5-1ike activity in Caenorhabditis elegans 
better than did a construct containing the Src SH2, indicat- 
ing a correlation of binding specificity with biological ac- 
tivity. 
Therefore, although all SH2 domains bind to phospho- 
tyrosyl proteins, they are not promiscuous in choosing 
partners. Ligand specificity is largely determined by the 
linear sequence surrounding the pTyr. However, these 
specificities are not absolute, and there may be more than 
one SH2 within a cell with high affinity for a particular 
ligand. Therefore, in vivo, the ability of an SH2 domain to 
engage a particular phosphoprotein may depend critically 
on the local concentration of proteins as well as the modu- 
lating effect of other domains found on interacting pro- 
teins. We take up these complications in later sections. 
In the section that follows, we discuss the structural basis 
for SH2 specificity. 
Figure 2. Schematic Diagram ofthe Src SH2 Domain, lUustrating the 
Orientation of the Bound Phosphopeptide 
The phosphopeptide backbone has been highlighted in yellow, while 
some SH2 residues in the ligand-binding site have been highlighted 
in orange and blue (see text for details). This figure is based on a 
figure that appeared in Waksman et al. (1993) and was redrawn by 
Chi-Hon Lee and John Kuriyan. 
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Figure 3. pTyr-Binding Sites 
The Src pTyr-binding site (A) and the Syp pTyr-binding site (B). SH2 
domain and phosphopeptide r sidues have been drawn in black and 
blue, respectively. Residues that are mentioned in the text have their 
names rendered in red, while noncovaient interactions areindicated 
by broken red lines (see text for details). For the sake of clarity, not 
all contacts between the pTyr and SH2 domain have been included. 
These figures are based on figures that appeared in Waksman et al. 
(1993) and Lee et al. (1994) and are reproduced by permission of the 
authors and publishers. 
SH2 Structure 
All SH2 domains solved to date contain a large central 
antiparalle113 sheet, two flanking ~ helices, and follow a 
general pattern of 13-~-I$-~-fl-13-13-m13. Given the similarities 
in SH2 secondary structure, a nomenclature was adopted 
to facilitate comparisons (Eck et al., 1993): the 13 sheets 
are lettered 13A, ~B, et cetera; the c~ helices are c~A and c~B; 
and loops are labeled by the 2 ° structures they connect. 
Residues are numbered consecutively within the 2 ° struc- 
tures. Figure 2 shows a schematic diagram of the Src 
SH2 domain bound to a high affinity phosphopeptide and 
illustrates the nomenclature. 
The pTyr-Binding Site 
SH2 domains bind specifically to pTyr-containing proteins 
and show little or no affinity for phosphoserine/threonine 
sequences. Structures of SH2 domains bound to pTyr pep- 
tides give a structural basis for this preference (Waksman 
et al., 1992). The pTyr side chain projects into a deep 
pocket. At the bottom of the crevice, the negatively 
charged phosphate is coordinated by a bidentate interac- 
tion with the positively charged side chain of Arg ~B5 (Fig- 
ure 3). Since Arg 13B5 is 7.5 J, removed from the m-carbon 
atom of the pTyr (in the Syp structure) (Lee et al., 1994), 
it is inaccessible to the shorter side chains of phosphoser- 
ine or Thr. This Arg is invariant, and mutation of the Arg, 
even to Lys, abolishes the ability of the Abl SH2 domain to 
recognize phosphoproteins (Mayer and Baltimore, 1993). 
The pTyr recognition site also contains an extensive 
network of hydrogen bonds to the phosphate and a num- 
ber of hydrophobic ontacts to the phenol ring. While one 
might think the architecture of the pTyr-binding site is 
strictly conserved, there is in fact some flexibility in its 
design. For Src and Lck, there are two amino-aromatic 
contacts to the phenol ring (one is supplied by Lys ~D6 
and the other by Arg ~A2; Figure 3A) (Eck et al., 1993; 
Waksman et al., 1993). Bonds between positively charged 
atoms and benzene rings have recently been described 
in a number of protein structures (Waksman et al., 1993; 
Miller, 1994); therefore, it was natural to think that these 
two amino-aromatic interactions would be critical for pTyr 
recognition. Apparently, at least for some SH2 domains, 
this is not the case. Syp is rare among SH2 domains in 
lacking Arg ~A2. Instead, it has a Gly. Furthermore, in the 
Syp structure, Lys 13D6, which supplied the other amino- 
aromatic contact in Src, contacts the phenol ring solely 
with its hydrocarbon chain and not with the amine (Figure 
3B). Despite the loss of the amino-aromatic interactions 
there are no major structural alterations in Syp's pTyr 
pocket (although Arg 13B5, which binds to the two terminal 
oxygens in Src, binds to the phenolic oxygen and a termi- 
nal phosphate oxygen in Syp; Figure 3) (Lee et al., 1994). 
A further demonstration of the plasticity of the pTyr-binding 
site is seen in the nuclear magnetic resonance (NMR) 
structure of the SH2 domain of PLC-'t,1, where the BC 
loop, which makes important hydrogen-bond contacts in 
the Src, Lck, and Syp structures, no longer directly con- 
tacts the phosphate (PLC-'t' may replace these contacts 
with stronger associations between the phosphate and 
positively charged residues found in the PLC-7 pocket) 
(Pascal et al., 1994). Thus, although certain residues may 
contribute greatly to pTyr-binding interactions in a given 
SH2 domain, they are replaceable in others. Within the 
SH2 domain kingdom, only Arg 13B5 is invariant. 
The Peptide.Binding Site: Act I (Enter Src and Lck) 
The first structure of a ligated SH2 domain was solved 
using a low affinity peptide (Waksman et al., 1992). In this 
structure, there were few contacts to the peptide chain. 
Now that there are structures of both low and high affinity 
ligands complexed to SH2 domains, it is clear that what 
differs between these ligands is not how they bind to pTyr, 
which is relatively unaltered, but rather the extent of inter- 
actions to the peptide chain. High affinity ligated structures 
were determined for Src and Lck bound to an 11-mer pep- 
tide, derived from hamster middle T antigen, that con- 
tained the Src family-binding motif pYEEI (Eck et al., 1993; 
Waksman et al., 1993). Four residues in the peptide, pY- 
EEl, make much more extensive contact with the protein 
than the other seven. Of these four residues, the most 
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elaborate pockets cradle the pTyr and lie +3. Binding of 
this peptide to the Src SH2 domain has therefore been 
described as "a two-pronged plug engaging a two-holed 
socket" (Waksman et al., 1993). The lie +3-binding pocket 
is lined, as expected, primarily with hydrophobic residues 
(see Figure 2). The EF and BG loops form part of the lie 
+3-binding pocket and have been described as a "set of 
jaws" that clamp down on the lie +3 residue (Eck et 
al., 1993). 
The glutamate residues (Y+I and Y+2) are both solvent- 
exposed in the Src and Lck structures, and there is no 
obvious glutamate-binding pocket. There are positively 
charged residues in the vicinity of the glutamates that may 
contribute to selectivity (e.g., Lys I~D3, Lys 13D6, and Arg 
~D'I ; see Figure 2). However, some of these residues are 
also found on SH2 domains that select for hydrophobic 
amino acids at the +1 and +2 sites. Moreover, the distance 
from these residues to the glutamates is too large for there 
to be a strong interaction. This is somewhat disturbing, 
since for Lck, the selectivity for a Glu at the +1 site is as 
high as it is for lie +3 (Songyang et al., 1993). Furthermore, 
in the PDGF receptor, a likely binding site for Src is pys791- 
pY581V (where both Tyrs are phosphorylated), while for the 
CSF-1 receptor, the site may be YS59TFI (Mori et al., 1993). 
Both of these sites significantly deviate from the putative 
consensus, pYEEI. Careful biochemical analysis and sys- 
tematic mutations of the consensus ligand motif and SH2 
domain are needed to assess better the contribution of 
individual residues toward binding specificity. 
The Peptide.Binding Site: Act II (Enter Syp 
and PLC.yl) 
Recently, the Syp and PLC-71 SH2 structures were deter- 
mined (Lee et al., 1994; Pascal et al., 1994). In contrast 
with Src and Lck, which are classified as group I ligand 
binders (pTyr-hydrophilic-hydrophilic-hydrophobic), Syp 
and PLC-71 are group II binders (pTyr-hydrophobic-X- 
hydrophobic). What is most strikingly similar about these 
four structures, besides the obvious pTyr-binding site, is 
the manner in which the peptide is held by the protein. 
A direct comparison of the Syp and Src ligated peptides 
reveals that when the peptides' c~-carbon atoms are com- 
pared, the backbone conformation from the pTyr to the 
+3 position are virtually identical (Lee et al., 1994). This 
conservation had been predicted by Harrison and cowork- 
ere, who had noted in the Lck structure that the extended 
peptide-proteirl interface contained extensive contacts to 
the peptide's backbone that"suggest tight binding will gen- 
erally require the peptide conformation seen in this struc- 
ture" (Eck et al., 1993). 
What was unexpected in the new structures is the length 
of the peptide that contacts the protein. For Syp, there 
are contacts out to the +5 position, and for PLC-~,I they 
extend out to +6. Furthermore, the binding site for the 
peptide in both of these structures is a shallow groove-- 
in contrast with the "two-holed socket" of Src and Lck. A 
number of features account for the different binding pock- 
ets. All group I SH2s (Src and Lck) contain bulky side 
chains at position 13D5 (Tyr or Phe) (Songyang et al., 1994). 
In contrast, group II SH2s (Syp and PLC-~,I) contain 
smaller, nonaromatic side chains at 13D5. Tyr 13D5 acts as 
the divider between the pTyr and lie +3-binding pockets 
(see Figure 2). In its absence, a slender channel is created 
between the two pockets. This groove is hydrophobic and 
provides to hydrophobic residues at the +1 position a place 
to bury their side chains partially. 
Further selectivity for hydrophobic residues by the Syp 
and PLC-~fl SH2 domains is imparted by the BG loop. The 
conformation and length of this loop varies among the SH2 
domains, as does the extent to which it contacts the ligated 
peptides. Therefore, this loop may play an important role 
in determining peptide selectivity. In the Src and Lck struc- 
tures, the BG and EF loops seal off the lie +3-binding 
pocket. This action forces the peptide chain away from 
the protein and precludes significant interactions beyond 
lie +3 (see Figure 2). In the Syp and PLC-71 structures, 
these loops are less constraining, and a groove opens up 
beyond the +3 site, which allows for the more extended 
contacts to the peptide chain. 
Consistent with the structural studies, mutation of the 
+5 residue in the Syp peptide results in a >100-fold de- 
crease in the peptide's affinity. This result explains why 
truncation of Syp-specific peptides to 6-mers (mentioned 
above) severely diminishes binding to the protein. Similar 
biochemical studies for PLC-71 suggest that the extended 
contacts (+5 and +6) are not critical for high affinity interac- 
tions (Case et al., 1994). It is unclear why these results 
and the NMR structure are at odds. Others have reported 
that residues on the N-terminus of the pTyr alter the bind- 
ing affinity of peptides to some SH2 domains (Bibbins et 
ai., 1993; Nishimura et al., 1993). These results suggest 
that although much has been learnt about SH2 domain 
specificity, there is still more to go. The future will no doubt 
see more structures, more bound ligands, and, hopefully, 
quantitative analysis of the binding interactions between 
whole phosphoproteins and SH2 domains. 
Kinetics of Ligand Binding 
High affinity phosphopeptides bind to SH2 domains rap- 
idly: kon, - 1 x 105 M-is -1 to 2 x 106 M-is -~, but dissocia- 
tion is also moderately fast, even for high affinity ligands: 
ko,, - 0.1 s -~ (t,/2 ~ssoc,atio. = 5-10 s) (Panayotou et al., 1993). 
Since the response time of cells to growth factors is min- 
utes to hours, even after SH2-containing proteins have 
engaged an RTK, the signal emanating from the receptor 
may remain open to the modulatory effect of phosphatases 
as well as competing SH2-containing proteins. Interest- 
ingly, the difference between high and low affinity ligands 
appears to be due to differences in ko., with little variation 
in ko, (Felder et al., 1993; Panayotou et al., 1993; Maren- 
gere et al., 1994). This seems surprising in light of the 
crystal structures, which show that high affinity ligands 
make more extensive contacts to the protein than do low 
affinity ligands. However, binding to the SH2 domain by 
a phosphopeptide may be a two-step process. In the first 
step, the phosphopeptide may become weakly associated 
with the protein to form an unstable intermediate complex. 
The rate-limiting transition state may occur subsequently, 
as the pTyr becomes tightly locked into its binding pocket. 
Therefore, during dissociation of the peptide, the rate- 
limiting step could be disengagement of the pTyr. Since 
the pTyr is held in the binding pocket in a similar manner 
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for both high and low affinity ligands, ko, would be similar 
for both ligands. 
Do SH2 Domains Bind in a Non.pTyr.Dependent 
Manner? 
A number of reports claim that SH2 domains interact with 
proteins in a non-pTyr-dependent manner (Muller et al., 
1992; Bibbins et al., 1993; Cooper and Kashishian, 1993). 
In at least one case, the interaction described (binding of 
the SH2 domains from the noncatalytic p85a subunit of 
PI3K to the catalytic p110 subunit) could not be repro- 
duced by another lab and subsequently has been ascribed 
to a different region of p85a (Hu and Schlessinger, 1994; 
Klippel et al., 1994). Furthermore, the pTyr-independent 
interactions described so far are weaker than SH2-pTyr- 
dependent interactions (Muller et al., 1992; Bibbins et al., 
1993). However, if the pTyr-independent interactions oc- 
cur intramolecularly, then even relatively weak interac- 
tions could be used by a protein as a means of allosteric 
regulation. Therefore, the possibility that some SH2 do- 
mains have an effector region outside the pTyr-binding 
site is an intriguing but at this time speculative idea. 
SH2 Domain Function 
How does the binding of an SH2-containing protein to a 
Tyr-phosphorylated protein help transmit a signal? First, 
binding may alter the subcellular localization of a protein, 
bringing it closer to its substrate, or closer to a protein that 
modifies it. Second, binding may induce conformational 
changes that alter the catalytic activity of the interact- 
ing proteins. SH2-containing proteins use both of these 
methods. 
Propagation of Signals by a Change 
in Subcellular Localization 
The RTK-mediated Ras activation pathway has been the 
paradigm for activation by localization (Pawson and 
Schlessinger, 1993). Ras, a GTPase associated with the 
plasma membrane, is activated bythe guanine nucleotide 
exchange factor SOS. Even in quiescent cells, SOS is 
found in the cytoplasm engaged with the adaptor molecule 
Grb2 via the latter molecule's two SH3 domains. Activation 
and autophosphorylation of the epidermal growth factor 
receptor (EGFR) creates a binding site for the SH2 domain 
of Grb2 and recruits the Grb2-SOS complex to the mem- 
brane, bringing SOS into proximity with its Ras substrate. 
At the membrane, SOS may be Thr- or Ser-phosphory- 
lated. However, the intrinsic catalytic activity of SOS in 
activated or quiescent cells is indistinguishable, leaving 
the biological relevance of SOS phosphorylation unknown 
(in yeast, phosphorylation of a Ras exchanger, Cdc25, 
by a cAMP-dependent kinase releases Cdc25 from the 
membrane; Rozakis-Adcock et al., 1993). Therefore, in 
EGF-treated cells, Ras activation is due to the increased 
local concentration of SOS. Localization is also important 
for the pathways that activate P LC-y1, PI3K, and RasGAP, 
because like SOS, these molecules are cytosolic, and their 
substrates, phospholipids and Ras, are membrane bound. 
A variation on the EGFR/Grb2 pathway is used by 
PDGFR. PDGFR does not bind directly to Grb2 but instead 
contains a binding site, py10og, for the tyrosine phospha- 
tase Syp (Lechleider et al., 1993; Li et al., 1994). Syp, 
upon binding to the PDGF receptor, is Tyr-p hosphorylated, 
and it is thought that phosphorylation of Syp provides a 
docking site for the Grb2-SOS complex. In PDGFR mu- 
tants that carry multiple Tyr to Phe mutations, the pres- 
ence of yloe9 is sufficient but not necessary for Ras activa- 
tion by PDGF (Valius and Kazlauskas, 1993). Therefore, 
Syp-independent pathways for Ras activation must also 
exist. There is also genetic evidence that the PDGFR/Syp/ 
Grb2/SOS pathway is physiologically relevant. In Dro- 
sophila melanogaster, the Syp homolog, corkscrew, posi- 
tively transmits signals from the putative RTK, torso, on 
a pathway that mediates cell fate determination for the 
head and tail regions of Drosophila embryos. SOS and 
Ras are also essential for this pathway. The ability of Syp 
to act as an adaptor molecule and bring Grb2 to the kinase 
may explain the apparent paradox of a phosphatase aiding 
the signaling pathway of a kinase (Li et al., 1994). The 
function of Syp's phosphatase activity on this pathway, 
however, remains a mystery. 
Grb2 appears to be (almost) a universal adaptor protein 
in tyrosine kinase signaling pathways. Besides Syp and 
EGFR, it also binds to Tyr-phosphorylated forms of Shc 
and insulin receptor substrate 1 (IRS-1) (Pawson and 
Schlessinger, 1993). However, phosphorylated Shc and 
IRS-1 do not stably associate with the membrane, which 
suggests that they may use a presently unknown mecha- 
nism to bring about Ras activation. 
Phosphorylation of SH2.Containing Proteins 
The binding of an SH2-containing protein to a tyrosine 
kinase increases the likelihood that the SH2-containing 
protein is going to get phosphorylated (kinases that modify 
proteins frequently stably associate with their substrates, 
e.g., rhodopsin kinase and the stress-activated protein ki- 
nase family; Lefkowitz, 1993; D~rijard et al., 1994; Kyriakis 
et al., 1994). Phosphorylation of SH2-containing mole- 
cules may recruit other molecules to the activated com- 
plex; e.g., phosphorylation of Syp by PDGFR created a 
new binding site for Grb2. Alternatively, phosphorylation 
may alter the intrinsic catalytic activity of the SH2-contain- 
ing molecule; e.g., EGFR phosphorylation of PLC-~,I in- 
creases the catalytic activity of PLC-71 toward profilin- 
bound phosphatidylinositol (4,5)-bisphosphate (PtdlnsP2; 
hydrolysis of PtdlnsP2 frees profilin, which then regulates 
actin polymerization) (Aderem, 1992). 
The JAK/STAT pathway provides another rich example 
of how phosphorylation of an SH2-containing molecule is 
used in signal transduction pathways (Darnell et al., 1994). 
JAKs are members of a family of nonreceptor tyrosine 
kinases, the Janus kinases, that contain two putative tyro- 
sine kinase domains. Their name is derived from that of 
the Roman god, Janus, god of gates and doorways and 
the porter of heaven; he is often portrayed with two faces 
looking in opposite directions (thus, the first month of the 
year is January). JAKs associate with membrane-bound 
receptors, e.g., PDGFR and the interferon (~ receptor. 
When a cell is treated with growth factors or cytokines, JAK 
family members may be activated and then phosphorylate 
members of the STAT protein family. Phosphorylated 
STATs form homo- and probably heterodimers, held to- 
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gether by a reciprocal interaction of the SH2 domain on 
one STAT with a pTyr on the opposing STAT. U nphosphor- 
ylated STATs are cytoplasmic, but upon phosphorylation 
and dimerization they, along with other molecules that 
bind to the dimer, translocate to the nucleus. In the nu- 
cleus, the complex binds to specific DNA sites and acti- 
vates transcription. STATs are an example of transcription 
factors regulated by Tyr phosphorylation. 
IRS.I: Phosphorylation of  a Signaling Molecule 
That Does Not Contain an SH2 Domain 
In insulin-stimulated cells, a major substrate for the insulin 
receptor is the cytosolic protein IRS-1. It is not entirely 
clear how IRS-1, which lacks an SH2 domain to direct it to 
the membrane, gets phosphorylated. The insulin receptor 
kinase is specific for certain IRS-1 Tyr-containing motifs 
(Shoelson et al., 1992). However, in general, tyrosine ki- 
nases are not as specific as serine and threonine kinases. 
Moreover, IRS-1 has 21 potential Tyr phosphorylation 
sites, at least eight of which can be phosphorylated (Myers 
et al., 1994). Whether the insulin receptor is specific for 
all of these phosphorylation sites is not known. In any 
event, once IRS-1 is phosphorylated it associates with a 
number of proteins, including PI3K, Grb2, Syp, and Nck. 
Because IRS-1 interacts with so many proteins, it has been 
dubbed a "docking protein". The docking protein links the 
insulin receptor to many SH2-containing signaling path- 
ways, and in this respect it is analogous to the cytoplasmic 
tail of the PDGFR. In these signaling complexes, many 
opportunities might exist for interactions between neigh- 
boring molecu lee. However, to date, there is little evidence 
for such interactions, and it is not even known whether 
signaling complexes containing proteins from multiple 
pathways generally form under physiological conditions. 
AIIo~teric Activation of SH2.Containing Proteins 
Both the Syp phosphatase and PI3K show enhanced cata- 
lytic activity upon binding to phosphopeptides (Carpenter 
et al., 1993; Shoelson et al., 1993; Sugimoto et al., 1994). 
For Syp, the increase in activity can be more than 50-fold 
for PI3K it is about 5-fold. While it is conceivable that phos- 
phoprotein binding induces a conformational change in 
the SH2 domain that is then transmitted to the catalytic 
domain, the crystal structures uggest that this is unlikely. 
Very little structural alteration is seen within SH2 domains 
upon ligand binding (Lee et al., 1994). However, although 
SH2s may not be materially altered by binding, their rela- 
tion to the rest of the protein could be changed. Thus, an 
internal interaction of the SH2 with the protein could be 
modified when the SH2 binds to an exogenous ligand. The 
best example of this comes from the Src family, where a 
pTyr residue in the carboxyl tail, py52~, interacts with the 
Src SH2 domain to regulate the kinase negatively (Superti- 
Furga et al., 1993). A somewhat similar SH2/carboxyl tail 
repression mechanism might be used by the Syp phospha- 
tase as limited protease digestion of Syp's carboxyl tail 
activates the phosphatase and mitigates the increase in 
activity seen upon addition of phosphopeptides (Sugi- 
moto et al., 1994). Both Syp and PI3K contain two SH2 
domains, and there is evidence that engagement of both 
domains is required for maximal stimulation of the cata- 
lytic domain. 
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Figure 4. SH3 Peptide Ligands 
3BP-1, 3BP-2, RLP1, and RLP2 are class I ligands, while LPR1 and 
the SOS-derived peptide are class II ligands (see text for details). 
Regions of these ligands that are contained in the PPII helix in ligated 
structures have been highlighted inyellow (a structure for the ligated 
form of the SOS-derived peptide has not been determined, so this 
peptide is not shaded). Residues that have been identified as critical 
for high affinity interactions with SH3 domains have been boxed, while 
residues that contribute l ss to binding have been circled (thorough 
mutagenic analysis has not yet been done for 3BP-2, RLP2, and the 
SOS-derived peptide, so these peptides have not been marked). 
SH3 Domains 
While the biological functions of SH2 domains are fairly 
well understood, understanding the biology of SH3 do- 
mains has lagged behind. A key for deciphering the func- 
tion of SH3 domains came when two SH3-binding pro- 
teins, 3BP1 and 3BP2, were identified by screening a 
cDNA expression library with the Abl SH3 domain (Cic- 
chetti et al., 1992). The location of the possible binding 
regions on 3BP1 and 3BP2 was narrowed to - 10 amino 
acid Pro-rich sequences (Figure 4) (Ren et al., 1993). Since 
then, a number of in vivo SH3 ligands have been identified, 
e.g., SOS, PI3K, and p47 Ph°x, and the binding sites have 
similarly mapped to Pro-rich sequences (Finan et al., 1994; 
Musacchio et al., 1994b). Other high affinity SH3 peptide 
ligands were identified by screening with a chemically syn- 
thesized peptide library (Chen et al., 1993; Yu et al., 1994). 
Schreiber and coworkers tarted with a biased random 
peptide library, XXXPPXPXX, where X is any amino acid 
other than Cys, and found that both the Src and PI3K SH3s 
selected for two classes of ligands (the bias was based 
on residues found in 3BP1 and 3BP2; without the bias, 
no high affinity ligands were found). Class I ligands are 
RXLPP(SPXX, where 5 is L for Src and R for PI3K. Class 
II are XXXPPLPXR for both Src and PI3K. In class I ligands 
for Src and PI3K, an Arg is N-terminal to the Pro-rich se- 
quence, while for class II ligands it is C-terminal. Examples 
of class I and II ligands used in structural studies are listed 
in Figure 4. Mutational analysis has identified residues 
that are particularly important for binding, and these resi- 
dues are boxed in Figure 4; less important residues have 
been circled (Ren et al., 1993; Yu et al., 1994; Feng et 
al., 1994). All high affinity SH3 ligands identified so far 
contain a PXXP motif, and the sequences in Figure 4 have 
been aligned by this motif. In the following section, we 
consider the structural basis for SH3 selectivity. 
SH3 Structure 
Structures for eight SH3 domains have been reported, 
four of these with ligands (PI3K, Abl, Fyn, Src) (Feng et 
al., 1994; Musacchio et al., 1994a; Yu et al., 1994). Al- 
though there are variations among these structures, the 
overall topology is well conserved. The basic fold consists 
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Figure 5. The 3BP-1 Peptide Bound to the Abl SH3 Domain 
The numbering on the residues of the peptide corresponds to the 
numbering for the 3BP-1 peptide in Figure 4. Residues 4-10 of the 
peptide adopt a PPII-helical conformation (see text for details). Pepide 
color coding: nitrogen, blue; oxygen, red; and carbon, white. Some 
residues and regions of the Abl SH3 domain that define the ligand- 
binding surface are also highlighted (see Musacchio et al., 1994a, for 
a more complete description of the interactions). This figure previously 
appeared in the paper by Musacchio et sl. (1994a) and is reproduced 
by permission of the authors and publisher. 
of five antiparalle113 strands (named "A" to "E") that pack 
to form two perpendicular 13 sheets. A hydrophobic patch 
that contains a cluster of conserved aromatic residues and 
is surrounded by two charged and variable loops (the AB 
and BC loops) forms the ligand-binding pocket. 
The first ligated structure was of the PI3K SH3 bound 
to the peptide RLP1 (see Figure 4; Yu et al., 1994). As 
with the SH2 domain, very little structural alteration in the 
SH3 is detected upon ligand binding. The central portion of 
this peptide, residues Arg4 to Pro10, adopts a polyproline 
type II (PPII) helix (the numbering of these residues refers 
to the numbers shown above the peptide sequences in 
Figure 4). PPII helices appear in all bound SH3 ligands 
examined so far. Figure 5 illustrates the PPII helical confor- 
mation of the 3BP-1 peptide bound to the Abl SH3 domain 
(the PPII helical regions of other SH3 ligands have been 
highlighted in yellow in Figure 4). Though the PPII motif 
was first identified in 1955 in crystals of L-polyproline, their 
ubiquity in globular proteins has only recently been recog- 
nized (Adzhubei and Sternberg, 1993). In contrast with 
their more renowned counterpa~s, the 310 and (~ helices, 
which are predominantly right handed, PPII helices are 
left handed. The number of residues per turn in a perfect 
PPII helix is -3.0; therefore, we can imagine the PPII 
portion of the bound peptide as a trigonal prism (Figure 
6A is drawn for the Src-binding peptide RLP2). Two edges 
of the prism contact the protein (the SH3 domain would 
be where your face is) (Yu et al., 1994). This agrees well 
with the critical residues identified on RLP1 by mutational 
analysis. In globular proteins, most of the amide nitrogens 
and oxygens in the PPII helix form hydrogen bonds to 
water. PPII helices therefore tend to be solvent-exposed 
and mobile, ideal sites for interactions with other proteins. 
No hydrogen bonds between the peptide backbone and 
SH3 domain were seen in the PI3K structu re, and only two 
A 
~00- 
/ " 1' 
I/ I ' 
~"NH3 + j 
1 - - -~  I 
2 ~ CO ,C 
,_, ?c-% 
B 
NI t3  + 
RII O~ 
COO-  
l 
N 
co  
I -~- -  2 
co  
I 
C 
CO 
2 ~ 1  
W-% 
co  I 
Figure 6. Schematic Diagram Illustrating PPII Helices for Src-Binding 
Peptides 
RLP2 (A) and LPR1 (B). Below each illustration is a stick figure for 
two residues that are found in each helix. Notice that two backbone 
bonds (numbered in red) separate he Pro and non-Pro side chains, 
while in (C), three backbone bonds separate the side chains (see text 
for details). 
hydrogen bonds were seen in the Abl and Fyn structures 
(Musacchio et al., 1994a). Therefore, the driving force for 
bonding comes primarily from interactions between the 
ligand side chains and the protein. 
Although Pro residues are not strictly required for PPII 
helices ( -25% of PPII helices in globular proteins do not 
contain Pro [Adzhubei and Sternberg, 1993]), the propen- 
sity of Pro to adopt this conformation readily explains their 
presence in SH3 ligands (SH3-binding, Pro-rich peptide 
ligands may exist as PPII helices free in solution; Musac- 
chio et al., 1994b). The two critical Pros in the PXXP motif 
directly pack against the SH3-binding protein, lodging 
themselves into a host of conserved, mostly aromatic, resi- 
dues. The N-terminal Arg found on the class I ligands RLP1 
and RLP2 (Arg4; see Figure 4) engages in a critical electro- 
static interaction with Asp-99 (numbering is for Src); muta- 
tion of either Arg4 or Asp-99 severely disrupts ligand bind- 
ing (Yu et al., 1994). However, Asp-99 also binds the 
C-terminal Arg (Arg-12) in class II ligands LPR1 and SOS. 
Therefore, the orientations of class I and II ligands on Src 
are opposite! Compare Figures 6A and 6B (Feng et al., 
1994). Furthermore, the positions of the critical Pros on the 
face of the trigonal prism are exchanged with the non-Pro 
residues. This exchange keeps the distance between the 
prolyl ring and the non-Pro side chain constant (notice that 
in the stick figures in Figures 6A and 6B the two side chains 
are separated by two backbone bonds; if you change the 
position of the Pro and non-Pro within a stick figure, the 
side chains become separated by three backbone bonds; 
e.g., compare Figures 6B and 6C). Apparently, the SH3- 
binding pocket is flexible enough to accommodate both 
ligand orientations, and the tightest-binding class I and 
class II ligands have similar affinities for the SH3 of PI3K 
(8 uM and 13 I~M, respectively; Chen et al., 1993). The 
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lack of substantial hydrogen bonding to the peptide back- 
bone may further contribute to the orientation androgyny. 
Whether either orientation predominates in nature re- 
mains to be determined; the SOS peptide (see Figure 4) 
is likely to interact with Grb2 in a class II interaction (Feng 
et al., 1994), while the 3BP1-Abl interaction is class I ori- 
ented (Musacchio et al., 1994a). 
Like that of SH2, the specificity of SH3 is thought to 
be determined by the variable amino acids that surround 
invariant residues. This specificity is evident in that Abl 
SH3 does not bind well to Src-specific ligands, while Src, 
in turn, binds poorly to Abl-specific peptides (Rickles et 
al., 1994). However, Asp-99, the residue that may dictate 
Src's specificity for Arg4, is found in virtually every SH3 
domain (except Abl, which has a Thr). Moreover, the Fyn 
SH3 domain, which selected for a Src-like peptide 
(RXLPXXP) in a phage display library (Rickles et al., 1994), 
has a residue homologous to Asp-99, yet binds to the Abl- 
specific 3BP-2 peptide with fairly high affinity, -35 mM 
(Musacchio et al., 1994a). Therefore, specificity could be 
influenced by residues lying outside the PPII helix; for in- 
stance, in the Abl-3BP1 and Fyn-3BP2 structures, Pro2 
(which lies outside the PPII helix; see Figure 4) makes 
significant contact with the SH3 domain (Musacchio et 
al., 1994a). However, if longer peptides are needed, then 
perhaps in vivo specificity will depend upon nonlinear se- 
quences, i.e., tertiary structure. There is evidence that 
disparate regions of the human inmmunodeficiency virus 
(HIV) protein Nef mediate interactions with the SH3 do- 
main of Hck (Saksela et al., 1995). Nonlinear sequences 
might mimic the PPII helix and also provide additional re- 
gions that interact with the SH3 domain. Alternatively, SH3 
domains may carry only crude specificity constraints, while 
the fine tuning of protein-protein interactions could be 
determined by other modular domains on the interacting 
proteins. 
Interactions between SH2 and SH3 Domains 
SH2 and SH3 domains are found together on many pro- 
teins; might their activities be coordinated? There is evi- 
dence to suggest so. For instance, the c-Src kinase is 
negatively regulated by interactions between its SH2 do- 
main and its Tyr-phosphorylated C-terminal tail. However, 
this inhibition also requires a functional SH3 domain. Mu- 
tation of the SH3 activates the kinase and increases the 
accessibility of the SH2 domain to exogenous substrates 
(Superti-Furga et al., 1993). In addition, a phosphoprotein 
that associates with Src during mitosis, p68, has been 
isolated, p68 interacts with both the isolated Src SH2 and 
the SH3 domains, but neither domain competes for p68 
as well as the tandem SH2-SH3 module (Fumagalli et al., 
1994; Taylor and Shalloway, 1994). A similar synergism 
is observed in the binding of the 110 kDa actin filament- 
associated protein to Src's SH2 and SH3 domains (Flynn 
et al., 1993). 
Structural evidence in support of SH2-SH3 cooperativ- 
ity comes from Eck et al. (1994), who crystallized a frag- 
ment containing the Lck SH2-SH3 domains (Lck is a Src 
family tyrosine kinase member). In the Lck structure there 
are few intramolecular contacts between the SH2 and SH3 
domains; however, the fragment crystallized as a dimer 
and there are extensive intermolecular SH2-SH3 con- 
tacts. Interestingly, an SH2 Pro lies in the binding pocket 
of the opposing SH3 domain and is bound in an orientation 
similar to that of a PXXP Pro. The Lck SH2-SH3 fragment 
was also crystallized in the presence of a phosphorylated 
peptide that corresponds to Lck's carboxyl tail. While the 
peptide's pTyr binds in an orientation similar to that ob- 
served in SH2-peptide complexes, the peptide chain does 
not; it lies in the crease of the intermolecular SH2-SH3 
interface. This result is intriguing, and if c-Src exists as a 
dimer in vivo, it may explain why both a functional SH2 
and an SH3 are required for the negative regulatory effect 
of Src's phosphocarboxyl tail. To date, there is no evidence 
that c-Src does exist as a dimer in solution but, as Eck et 
al. point out, in vivo, Src is a membrane-bound protein, 
and membrane localization may favor dimer formation. 
Moreover, membrane-bound Src may further be concen- 
trated within the membrane at signaling center complexes 
(Lisanti et al., 1994). The consequences of cellular organi- 
zation on signal transduction pathways has been a largely 
unexplored area of cell biology. 
SH3 Function 
Mutational analysis first demonstrated the biological im- 
portance of the SH3 domain: mutation of the SH3 domain 
of the adaptor molecule v-Crk mitigates this protein's trans- 
forming potential. For the nonreceptor tyrosine kinases 
Abl and Src, deletion of the SH3 domain activates the 
transforming potential of the proto-oncogene products. 
The importance of SH3 domains in signal transduction 
pathways was highlighted in C. elegans, where mutation 
of either of SEM-5's two SH3 domains blocked vulval de- 
velopment (Mayer and Baltimore, 1993). Although our un- 
derstanding of the physiological role of SH3-mediated in- 
teractions is still at an early stage, recent studies suggest 
various places where SH3 interactions mediate critical 
protein-protein interactions. These interactions are used 
to organize protein complexes within the cell, bring sub- 
strates to enzymes, and regulate enzymatic activities, as 
discussed in the following sections. 
Role of SH3 in Cellular Localization 
Compartmentalization ofproteins plays an important role 
in the regulation of signal transduction processes. Many 
of the proteins that localize to the plasma membrane or the 
cytoskeleton contain SH3 domains (e.g., the actin-binding 
protein a-spectrin, nonmuscle myosin Ib, and the S. cere- 
visiae protein ABP-1), suggesting that SH3 domains medi- 
ate localization to these regions (Mayer and Baltimore, 
1993). Using a microinjection approach, Bar-Sagi et al. 
demonstrated that the SH3 domain of PLC-~, is responsible 
for the targeting of that protein to cytoskeletal microfila- 
ments, while both SH3 domains of Grb2, but not its SH2 
domain, are required for Grb2 localization to membrane 
ruffles (Bar-Sagi et al., 1993). Although many SH3-contain- 
ing molecules associate with actin filaments, SH3 domains 
probably do not directly bind to actin. It is also likely that 
SH3-mediated interactions between ~-spectrin and the 
Pro-rich C-terminal tail of the amiloride-sensitive Na + 
channel dictates that channel's localization to the apical 
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membrane of polarized epithelial cells. Since many ion 
channels contain Pro-rich sequences, this mechanism of 
localization may be generally applicable to ion channels 
(Rotin et al., 1994). 
There are also many examples o~,: SH3-mediated interac- 
tions influencing signaling pathways containing G proteins 
of 21 kDa. For example, the Grb2-SOS interaction modu- 
lates Ras activity (see above), and the C-terminal SH3 
domain of Grb2 binds the N-terminal SH3 domain of Vav, 
a hematopoietic-specific guanine nucleotide exchange 
factor (Ye and Baltimore, 1995). In S. cerevisiae, genetic 
analysis suggests that the SH3-containing protein Bern1 p, 
which regulates cell polarity, interacts with the guanine 
nucleotide exchange factor BUD5 and a GTPase-acti- 
vating protein, Bem2p. In addition, some guanine nucleo- 
tide exchange factors (e.g., Vav and CDC25) and guano- 
sine triphosphatase-activating proteins (e.g., RasGAP) 
contain their own SH3 domains (Mayer and Baltimore, 
1993). While the frequency of SH3 domains on small GTP- 
binding protein pathways uggests a common mechanism 
of regulation, what that mechanism might be is not known. 
SH3-mediated interactions also play a role in the assem- 
bly of the phagocyte NADPH oxidase system. Phagocyte 
NADPH oxidase catalyzes reduction of molecular oxygen 
to superoxide. The NADPH oxidase consists of a mem- 
brane-bound flavocytochrome b, composed of two sub- 
units, gp91 phox and p22 ph°x. Activation of the oxidase occurs 
when a small G protein, p21 ra°, and three cytosolic SH3- 
containing proteins, p47 ph°x, p67 p~°x, and p40 ph°X, translo- 
cate to the membrane. The two SH3 domains of p47 ph°x, 
both of which are required for the assembly of the oxidase 
complex, bind to p22 ~h°x and p67 ph°x (Sumimoto et al., 
1994). In quiescent cells, the p47 ph°X SH3 domains may 
be blocked by an intramolecular interaction. They are un- 
masked in vitro by activators of the oxidase, such as ara- 
chidonic acid and sodium dodecyl sulfate. Interestingly, 
the point mutation P156Q, found in a patient with chronic 
granulomatous disease, occurs in a Pro-rich region of 
p22 ph°x and abolishes interaction with the p47 ph°x SH3 do- 
main. The C-terminal SH3 domain of p67 ph°X also binds to 
p47 ph°X (Finan et al., 1994). These results reveal that a 
complex SH3 network directs the assembly of the phago- 
cyte NADPH oxidase system. Apparently, in this system, 
SH3-mediated interactions are regulated in contrast with 
the Grb2/SOS SH3-mediated contacts, which are consti- 
tutive. 
Role of SH3 in Regulating Enzymatic Activities 
As was previously mentioned for c-Src, SH3-mediated in- 
teractions negatively regulate the kinase activity of nonre- 
ceptor tyrosine kinases. The Abl tyrosine kinase is also 
negatively regulated by its SH3 domain (Mayer and Balti- 
more, 1993). Although c-Src is activated by mutations in 
the SH3 domain, in the context of a constitutively active 
variant of c-Src, Y527F, mutations in the SH3 domain de- 
crease transforming activity. However, in another acti- 
vated variant of c-Src, E378G (a mutation within the kinase 
domain), the SH3 domain is not required for the trans- 
forming activity (SeideI-Dugan et al., 1992). It is not clear 
why there are different requirements for the SH3 domains 
in different contexts. 
An SH3-mediated interaction is also implicated in the 
activation of dynamin (Gout et al., 1993). Dynamin is a 
100 kDa microtu bule-activated GTPase that plays a critical 
role in the initial stages of endocytosis. Dynamin's GTPase 
activity is activated by the binding of SH3 domains from 
Grb2, Src, Fgr, and Fyn (although this activation is weaker 
than that stimulated by microtubules). This suggests that 
the association of SH3-containing signaling proteins with 
dynamin may regulate endocytosis. 
Role of SH3 in Recruiting Specific Substrates 
to the Enzyme 
Besides SH2-mediated interactions, nonreceptor tyrosine 
kinases may also use SH3-mediated interactions to target 
themselves to some of their substrates. For instance, the 
Abl tyrosine kinase has binding sites selective for the SH3 
domains of the Crk, Grb2, and Nck adaptor molecules. It is 
only upon binding to Abl that Crk becomes phosphorylated 
(Ren et al., 1994; Feller et al., 1994). The SH3 domain of 
Src family tyrosine kinases may target Src to its sub- 
strates: AFAP-110 and p68 (Flynn et al., 1993; Fumagalli 
et al., 1994; Taylor and Shalloway, 1994). Stable binding 
of these substrates to Src requires both the Src SH3 and 
the SH2 domains. This has led to the suggestion that bind- 
ing of Src to these substrates is initiated by SHS-mediated 
interactions, followed by Tyr-phosphorylation, and ends 
with stable complex formation that is mediated by both 
SH3 and SH2 interactions. The stable association of tyro- 
sine kinases with their substrates through noncatalytic do- 
mains may block the access of other substrates to the 
kinase. Signaling by tyrosine kinases may therefore in- 
volve pathways that require phosphorylation of only stoi- 
chiometric amounts of substrates. 
Role of SH3 in Interacting with Viral Proteins 
Because SH3-mediated interactions are critical for many 
cellular processes, it is no wonder that many viruses have 
pirated modified forms of SH3-containing proteins for their 
own devices (e.g., the Abelson murine leukemia virus). 
However, some viruses have evolved novel proteins to tap 
into tyrosine kinase signaling pathways. Recently, the HIV 
Nef protein was found to have a conserved PXXP motif 
that mediates Nef interaction with the SH3 domains of Hck 
and Lyn (Saksela et al., 1995). The PXXP motif is required 
for the higher replicative potential of Nef-bearing viruses, 
suggesting that the virus uses the SH3-mediated interac- 
tion to regulate a signaling pathway that facilitates viral 
growth. 
PH Domains 
The PH domain is a region of approximately 100 amino 
acids found in a wide variety of signaling and cytoskeletal 
proteins. The pleckstrin protein, the major protein kinase 
C substrate in platelets, has two such domains and was 
the first protein in which the domain was recognized (Has- 
lam et al., 1993; Mayer et al., 1993). The sequence homol- 
ogy of the PH domain among proteins is generally low 
(Musacchio et al., 1993). The structure of three PH do- 
mains--the N-terminal PH domain and those from spectrin 
and dynamin--have been solved by NMR analysis (Down- 
ing et al., 1994; Macias et al., 1994; Yoon et al., 1994; 
Ferguson et al., 1994). Despite the low sequence homol- 
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Figure 7. Schematic Diagram of the Spectrin PH Domain 
This figure previously appeared in the paper by Gibson et al. (1994) 
and is reproduced by permission of the authors and publisher. 
ogy among these domains, the peptide fold seen in these 
structures is virtually the same and provides structural 
evidence that the PH domain is a real functional unit. The 
basic PH fold contains two antiparalle113 sheets and a long 
C-terminal a helix (Figure 7). The PH structures differ most 
in the loop regions between 13 strands. In particular, the 
CD loop tolerates large insertions (Gibson et al., 1994). 
Interestingly, for the PH domain of PLC~, the protein's 
two SH2 domains and one SH3 domain are predicted to 
insert into this loop. Many of the conserved hydrophobic 
residues found in PH domains are located in the interior 
of the protein (in contrast with the SH3 domain, where 
they form the aromatic-rich PPII-binding pocket), while the 
highly conserved charged residues are solvent-exposed. 
On one side of the PH domain there are a narrow cleft, 
three variable loops, and clusters of positive charges. This 
side of the molecule has been hypothesized to be the site 
of ligand binding (Gibson et al., 1994). 
The function of PH domains is not known, although the 
presence of PH domains in a wide variety of proteins sug- 
gests that, like SH2 and SH3 domains, they mediate pro- 
tein-protein interactions. Several PH domains bind to the 
13~, subunits of heterotrimeric G proteins. However, these 
interactions only require the C-terminal portion of the PH 
domain and also require residues that lie outside the PH 
domain, so it is not clear whether these interactions can 
be generalized for other PH domains. Mutations in the 
N-terminal portion of the PH domain found in the nonre- 
ceptor tyrosine kinase Btk result in the immune deficiency 
disorder agammaglobulinemia and illustrate the impor- 
tance of this region of the PH domain (Gibson et al., 1994). 
Recently, it was suggested that PH domains might not 
serve as mediators of protein-protein interactions, but 
rather as mediators of protein-lipid interactions. Using a 
centrifugation assay, Harlan et al. (1994) reported that a 
number of PH domains associate specifically with lipid 
vesicles doped with PtdlnsP2. This interaction involves the 
previously mentioned positively charged area on the PH 
domain. The generality and biological relevance of PH- 
PtdlnsP2 interactions-and whether PH domains display 
other binding functions--remains to be determined. 
Perspectives 
We have now reached the point in our understanding of 
these three modular domains where their occurrence and 
their structures are well characterized. For SH2 and SH3, 
but not PH, binding sites have been well delineated, and 
the structural basis of recognition and specificity is moder- 
ately clear. However, many questions remain open. These 
have been highlighted above and will not be reiterated. 
The issues for PH are much more open than for the others, 
because its binding specificity is not yet apparent. It is the 
most variable of the three in sequence; it may not have 
a stereotyped core-binding activity and could depend 
more on three-dimensional protein structure for its binding 
specificity. It should be remembered that the prototype 
binding protein, the immunoglobulin, binds to either linear 
epitopes or ones composed of segments from various 
parts of the linear structure, and there is nothing in com- 
mon among the sites of binding. 
There is sure to be much excitement in the future about 
the roles that these domains play in particular biological 
processes. Having already seen that they can mediate 
dimerization, bring proteins to their substrates at mem- 
branes, bring substrates to enzymes, modify the activities 
of enzymes, and aggregate subunits of multiprotein com- 
plexes, we can expect new classes of functions to emerge. 
Ultimately, the recognition of modular binding domains 
will take its historic place as one of the key events that 
will have allowed biologists to comprehend the full variety 
of mechanisms inherent in the signal transduction path- 
ways of cells. 
After submission of this review, there were three other 
reports of high-resolution structure determinations of SH3 
domains bound to class II ligands: Lim et al. (1994), Tera- 
sawa et al. (1994), and Goudreau et al. (1994). These re- 
ports also demonstrate that class I and II ligands bind 
to SH3 domains in opposite orientations. In addition, a 
solution structure for the PH domain of dynamin has been 
reported: Fushman et al. (1995). 
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